Staff turnover in EUR640,762857,020549,166617,2421,292,076
Staff turnover in EUR640,762857,020549,166617,2421,292,076
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)0.760.871.40164.441.65
Dividend per share-----
Basic earnings per share-23.44-8.42-5.41-1.232.58
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover1,146.31,981.9983.7682.21,123.5
Operating income (EBIT)-1,459.9-545.9-455.3-134.8400.3
Earnings before taxes-1,714.5-653.6-543.0-176.6442.2
Annual net profit/ loss-1,743.8-657.9-545.1-187.5440.3
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets2,155.11,703.41,143.91,128.9978.3
Total fixed assets421.6555.3711.5473.7204.5
Total assets2,576.82,258.71,855.31,602.71,182.8
Liabilities
Total short-term liabilities2,390.32,459.91,635.11,154.4460.0
Total long-term liabilities538.1432.8937.11,072.1850.6
Total provisions0.00.00.00.00.0
Equity capital-351.7-634.1-716.9-623.8-127.8
Total liabilities2,576.82,258.71,855.31,602.71,182.8
Management:
Margaret McGlynn
John Shiver
Richard Douglas
Charles Newton
David Mott
Gregg Alton
Rachel King
Richard Rodgers
John C. Jacobs
Elaine O'Hara
Henrietta Ukwu
Ian Watkins
Jim Kelly
John J. Trizzino
Mark Casey
Rick Crowley
Robert Walker
Ruxandra Draghia-Akli
Silvia Taylor
Troy Morgan
Board:
Shareholding in %:
Address: 21 Firstfield Road, 20878 Gaithersburg
T: +1-240-268-2000
F: +
I: http://www.novavax.com
E: [email protected]